Document is current
Any future updates will be listed below
-
Authors
Buchholz, Florian https://orcid.org/0000-0003-3882-9132
Upterworth, Lina M. https://orcid.org/0009-0000-2632-3957
Tueffers, Leif
Groth, Espen E. https://orcid.org/0000-0003-0883-6366
Haas, Kira
Schütz, Daniel
Savietto Scholz, Abigail
Batra, Aditi
Pal, Surajit
Banerjee, Samarpita
Dubey, Badri N. https://orcid.org/0000-0002-8626-8918
Franzenburg, Sören https://orcid.org/0000-0001-6374-4910
Kalsdorf, Barbara
Rabe, Klaus F.
Nurjadi, Dennis
Rupp, Jan https://orcid.org/0000-0001-8722-1233
Andersson, Dan I. https://orcid.org/0000-0001-6640-2174
Sondermann, Holger https://orcid.org/0000-0003-2211-6234
Bramkamp, Marc https://orcid.org/0000-0002-7704-3266
Roemhild, Roderich https://orcid.org/0000-0001-9480-5261
Schulenburg, Hinrich https://orcid.org/0000-0002-1413-913X
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (GRK 2501, project 4.2)
Deutsche Forschungsgemeinschaft (EXC 2167-390884018)
Max-Planck-Gesellschaft (Fellowship)
Leibniz-Gemeinschaft (EvoLUNG)
- License Information
-
More Information
Article History
Received: 26 March 2025
Accepted: 13 March 2026
First Online: 26 March 2026
Competing interests
: The authors declare the following competing interest: Access to the CombiANT technology was provided by Rx Dynamics AB as a product BETA test. R.R. and D.I.A. are co-founders of Rx Dynamics AB. The company had no influence on study design, investigation, data analysis, manuscript writing and decision to publish. Apart from this, the authors declare no conflict of interest.
